arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Bristol-Myers Squibb Company

BMY Health Care Biotechnology: Pharmaceutical Preparations
$57.27
▲ +1.2% Today
as of Jun 7, 07:10 ET
Last 30 days -1.70% Apr 28 → Jun 05
$53.97 $55.75 $57.52 $59.30 $61.08 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$57.03
High
$57.81
Low
$56.79
Volume
$10M
Avg Vol
$14M
Mkt Cap
$116.2B
P/E (TTM)
18.90
Beta
52w High
$62.89
52w Low
$42.52
Div Yield
Shares Out

Overview

52-week range
$43
$63
72% of range
Avg surprise (last 1)
+19.2%
Avg reaction (last 1)
+0.3%
100% positive
Latest IV / EM
38%
EM ±3.5% · $57 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-5.89$-3.97$-2.04$-0.12$1.80 Actual $0.99Actual $0.93Actual $-5.89Actual $0.83Actual $0.60Actual $1.80Est $1.51Actual $0.64Actual $1.08Actual $1.31 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$0$3.2B$6.4B$9.7B$12.9B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $1.31 financials
Tue Sep 30, 2025Sep 2025 $1.08 financials
Mon Jun 30, 2025Jun 2025 $0.64 financials
Thu Apr 24, 2025Mar/2025 $1.80 $1.51 +19.2% +0.3% earnings
Mon Sep 30, 2024Sep 2024 $0.60 financials
Sun Jun 30, 2024Jun 2024 $0.83 financials
Sun Mar 31, 2024Mar 2024 $-5.89 financials
Sat Sep 30, 2023Sep 2023 $0.93 financials
Fri Jun 30, 2023Jun 2023 $0.99 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$11.49B$12.22B$12.27B$11.20B$11.89B$12.20B
Cost of revenue$3.42B$3.44B$3.37B$3.03B$2.96B$3.27B
Gross profit
Operating income
Net income$2.68B$2.20B$1.31B$2.46B$1.21B$1.68B
EPS (diluted)$1.31$1.08$0.64$1.20$0.60$0.83

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$9.57B$10.21B$15.73B$12.60B$10.88B$10.35B$7.89B$6.29B
Inventory$2.76B$2.69B$2.76B$2.74B$2.67B$2.56B$3.33B$3.08B
Total current assets$27.21B$29.39B$35.63B$33.22B$30.78B$29.78B$28.07B$26.89B
Total assets$86.48B$90.04B$96.89B$94.68B$92.43B$92.60B$93.67B$94.65B
Long-term debt$42.15B$42.85B$44.47B$44.47B$46.16B$47.60B$48.67B$48.86B
Total liabilities$66.37B$71.53B$78.29B$77.19B$74.98B$76.22B$76.47B$77.58B
Total equity$20.07B$18.47B$18.55B$17.43B$17.39B$16.34B$17.14B$17.02B

Implied volatility — last 90 days

32%35%37%40%42% Jun 07 — IV 38% · EM ±3.5%

Sector peers